Robotic Endomicroscopy to Better Define Resection Strategies Applied to Hepatic Surgery

NCT ID: NCT03718078

Last Updated: 2019-01-24

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

40 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-03-31

Study Completion Date

2020-01-07

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study aims at assessing the feasibility of Probe-based Confocal Laser Endomicroscopy (pCLE) during laparoscopic hepatic masses resection for intra-operative characterisation of hepatic masses and surgical margins assessment.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Colorectal cancer is the third most common cancer and third leading cause of cancer deaths in the Western countries. In France, 45.000 new patients develop colorectal cancer every year. The liver is the most common organ targeted by CRLM, representing 50%. Approximately, 15-25% of colorectal cancer patients have synchronous CRLM at initial workup, and 20-30% patients sustain subsequent liver metastases within few years following diagnosis.

The strategy for colorectal cancer liver metastasis resection and liver cancer has evolved to a parenchymatic sparing procedure. This technic aims to minimize surgical margins width while removing the tumor. Therefore, the current standard for resection margins is a margin width superior to 1mm. However, there is still a debate concerning the margin width. Indeed, with modern chemotherapy, several studies reported no statistical differences in the overall survival between R0 patients and R1 patients treated with chemotherapy. However, in order to preserve patients from chemotherapy treatments' adverse effects an intra-operative microscopic assessment of surgical margins should be set up in order to reduce R1 margins occurrence.

Ex vivo study:

Surgical specimens obtained during hepatectomy will be imaged to generate an atlas of pCLE images.

In vivo study:

Intraoperative characterization of sub-capsular hepatic masses and surgical margins will be assessed.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hepatocarcinoma Hepatic Metastasis Hepatic Tumor

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Confocal Laser Endomicroscopy

lt includes patients will undergo probe-based Confocal Laser Endomicroscopy during laparoscopic hepatic masses resection.

Group Type EXPERIMENTAL

Confocal Laser Endomicroscopy

Intervention Type DEVICE

The study is divided in two parts. For the two parts, patients will receive an intravenous injection of indocyanine green:

1. Ex vivo study

\- Images/sequences of normal and abnormal hepatic tissues and surgical margins will be acquired on surgical specimens
2. In vivo study - Intra-operative pCLE imaging will be performed on hepatic masses and surgical margins

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Confocal Laser Endomicroscopy

The study is divided in two parts. For the two parts, patients will receive an intravenous injection of indocyanine green:

1. Ex vivo study

\- Images/sequences of normal and abnormal hepatic tissues and surgical margins will be acquired on surgical specimens
2. In vivo study - Intra-operative pCLE imaging will be performed on hepatic masses and surgical margins

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

probe-based Confocal Laser Endomicroscopy CelioFlex UHD 5 probe Viziobot-P GastroFlex UHD probe Cellvizio 100 series pCLE Confocal Miniprobes

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Over 18 years
* Scheduled for a surgical resection of hepatic masses
* Provided signed informed consent

Exclusion Criteria

* Allergy to Indocyanine green (ICG)
* Kidney failure
* Pregnancy or breastfeeding
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Mauna Kea Technologies

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Institut Mutualiste Montsouris

Paris, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

David Fuks, MD

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2018-A02619-46

Identifier Type: OTHER

Identifier Source: secondary_id

MKT-2018-PERSEE-02-DIG

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.